Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | NA | High |
Rating | 4.0 | 4.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.83 | 1.72 |
NAV | ₹68.42 | ₹77.43 |
Fund Started | 12 Apr 2004 | 16 Feb 2004 |
Fund Size | ₹1539.01 Cr | ₹3264.25 Cr |
Exit Load | 1% for redemption within 90 days. | Exit load for units in excess of 30% of the investment,1% will be charged for redemption within 1 year |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 7.79% | 7.97% |
3 Year | 9.30% | 10.26% |
5 Year | 10.87% | 9.92% |
1 Year
3 Year
5 Year
Equity | 20.26% | 22.04% |
Cash | 5.83% | 8.38% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
HDFC Bank Ltd. | 1.85% |
ICICI Bank Ltd. | 1.62% |
Bharti Airtel Ltd. | 1.10% |
Bajaj Finserv Ltd. | 0.98% |
Hindalco Industries Ltd. | 0.94% |
Fortis Healthcare Ltd. | 0.71% |
Reliance Industries Ltd. | 0.66% |
Infosys Ltd. | 0.66% |
Tech Mahindra Ltd. | 0.64% |
Ultratech Cement Ltd. | 0.60% |
Name | Assets |
|---|---|
ICICI Bank Ltd. | 1.54% |
SBI Life Insurance Company Ltd. | 1.31% |
Maruti Suzuki India Ltd. | 1.02% |
HDFC Life Insurance Co Ltd. | 1.00% |
HDFC Bank Ltd. | 0.99% |
Infosys Ltd. | 0.97% |
NTPC Ltd. | 0.94% |
Hindustan Unilever Ltd. | 0.93% |
Sun Pharmaceutical Industries Ltd. | 0.87% |
Axis Bank Ltd. | 0.87% |
Name | Dhaval Joshi | Ritesh Lunawat |
Start Date | 10 Jun 2024 | 28 Dec 2020 |
Name
Start Date
Description | The scheme primarily seeks to generate regular income through a predominant exposure to debt and money market instruments. It also aims at capital growth through an equity exposure of maximum 25 per cent. | The scheme seeks to generate long-term capital appreciation by investments in money market and debt instruments. |
Launch Date | 12 Apr 2004 | 16 Feb 2004 |
Description
Launch Date